SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-008977
Filing Date
2022-05-16
Accepted
2022-05-16 16:31:30
Documents
14
Period of Report
2022-05-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20220516x8k.htm   iXBRL 8-K 34551
2 EX-99.1 tmb-20220516xex99d1.htm EX-99.1 78955
3 GRAPHIC tmb-20220516xex99d1001.jpg GRAPHIC 9018
  Complete submission text file 0001558370-22-008977.txt   244740

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20220516.xsd EX-101.SCH 3035
5 EX-101.LAB tmb-20220516_lab.xml EX-101.LAB 14087
6 EX-101.PRE tmb-20220516_pre.xml EX-101.PRE 9205
8 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220516x8k_htm.xml XML 4309
Mailing Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746
Business Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746 (774) 233-7300
Biostage, Inc. (Filer) CIK: 0001563665 (see all company filings)

IRS No.: 455210462 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35853 | Film No.: 22929801
SIC: 3841 Surgical & Medical Instruments & Apparatus